Cornell Alison A 4
4 · Zivo Bioscience, Inc. · Filed Jun 6, 2024
Insider Transaction Report
Form 4
Cornell Alison A
Director
Transactions
- Award
Common Stock
2024-06-05+60,724→ 144,578 total - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−3,179→ 0 totalExercise: $26.88Exp: 2031-10-11→ Common Stock (3,179 underlying) - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−707→ 0 totalExercise: $17.16Exp: 2032-12-15→ Common Stock (707 underlying) - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−23,240→ 0 totalExercise: $15.66Exp: 2032-12-18→ Common Stock (23,240 underlying) - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−3,626→ 0 totalExercise: $16.74Exp: 2033-06-11→ Common Stock (3,626 underlying) - Award
Common Stock
2024-06-05$7.96/sh+95,134$757,267→ 239,712 total - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−2,632→ 0 totalExercise: $21.66Exp: 2032-07-27→ Common Stock (2,632 underlying)
Footnotes (4)
- [F1]The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023.
- [F2]The canceled options were fully vested.
- [F3]The Issuer canceled options for an aggregate 33,384 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 7/28/2022, 12/16/2022, 12/19/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 60,724 shares of restricted stock.
- [F4]The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 6/12/2023 and vested as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2024 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date.